Circulating microRNAs: Macro-utility as markers of prostate cancer?

Luke A. Selth, Wayne D. Tilley, Lisa M. Butler

Research output: Contribution to journalReview articlepeer-review

32 Citations (Scopus)

Abstract

The realization that microRNAs (miRNAs) are frequently deregulated in malignancy has had a major impact on cancer research. In particular, the recent finding that highly stable forms of miRNAs can be accurately measured in body fluids, including blood, has generated considerable excitement. Here, we discuss the potential of blood-based circulating miRNAs as diagnostic, prognostic, and predictive biomarkers of prostate cancer. We also describe practical considerations that may influence identification and/or measurement of miRNA biomarkers in the circulation. Finally, evidence is prevented for the emerging concept that circulating miRNAs are actively released by their cells of origin and can modulate gene expression at distal sites. These mobile miRNAs, which we term 'hormomirs' because of their hormone-like characteristics, could act as local or long-range signals to maintain normal homeostasis or influence the development and progression of diseases such as cancer.

Original languageEnglish
Pages (from-to)R99-R113
JournalEndocrine-Related Cancer
Volume19
Issue number4
DOIs
Publication statusPublished - 1 Aug 2012
Externally publishedYes

Fingerprint Dive into the research topics of 'Circulating microRNAs: Macro-utility as markers of prostate cancer?'. Together they form a unique fingerprint.

Cite this